Skip to main content
AAO-HNSF 2026 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

ENT Pulse Presentation

Rhinology/Allergy

Alpha Gal: What It Is, What It Isn't, and Future Treatment Options

Monday, October 19, 2026
10:30 AM - 11:00 AM PT
Location: 403A
Disclosure(s):
Christine Blanche Franzese, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Alpha Gal syndrome (AGS), a potentially debilitating allergy to mammalian meat, is a recently recognized delayed IgE-mediated food allergy that has been increasing in prevalence. With implications that can impact surgery and medications usage, the understanding of AGS is evolving, with the first reported death due to AGS occurring in New Jersey. This rapid-fire session will cover what AGS is, including the mechanisms behind its development, diagnostic challenges, and clarify common misconceptions. With a focus on the latest research, attendees will gain insights into AGS management, how it might impact items used during surgery, and what medications should be avoided. Emerging treatment options will also be discussed.

Learning Objectives:

  • Upon completion, participant will be able to discuss pathophysiology and recognize the presentation of Alpha Gal syndrome.
  • Upon completion, participant will be able to discuss current treatment strategies for managing Alpha Gal syndrome, including what medications and surgical items to avoid.
  • Upon completion, participant will be able to debunk common myths and misconceptions about AGS